Skip to main content
Equibles

SUSQUEHANNA INTERNATIONAL GROUP, LLP

Position in RLMD — Relmada Therapeutics, Inc.

CIK 1446194 BALA CYNWYD, PA
Back to RLMD Full portfolio

Position in RLMD

as of Mar 31, 2026 · filed May 15, 2026
Position Value
$7,040,541
+$5,176,442 QoQ
Shares Held
1,011,572
+162.1% QoQ
Ownership
0.964%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
24 quarters on record
Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Common Shares in RLMD Over Time

Shares Held

Position Value (USD)

Derivatives in RLMD

reported options exposure · as of Mar 31, 2026
CallValue
$1,961,328
CallShares
281,800
PutValue
$325,728
PutShares
46,800

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Mar 31, 2026

SUSQUEHANNA INTERNATIONAL GROUP, LLP holds $1,176,415,994 across 355 Biotechnology names. RLMD ranks #39 (0.6% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 CYTK
Cytokinetics Inc
 898,951 $59,249,860
2 ALNY
Alnylam Pharmaceuticals, Inc.
 174,268 $57,660,053
3 AGIO
Agios Pharmaceuticals, Inc.
 1,344,953 $45,499,759
4 ABVX
Abivax S.A.
 381,282 $42,455,750
5 BBIO
BridgeBio Pharma, Inc.
 398,943 $29,625,507
6 INSM
INSMED Inc
 173,630 $28,391,977
7 CRSP
CRISPR Therapeutics AG
 593,406 $28,228,323
8 TERN
Terns Pharmaceuticals, Inc.
 521,571 $27,497,223

All Filings in RLMD

Export CSV
50 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $7,040,541 1,011,572
2026-03-31 $1,961,328 281,800
2026-03-31 $325,728 46,800
2025-12-31 $227,976 47,200
2025-12-31 $1,864,099 385,942
2025-09-30 $132,660 66,000
2025-09-30 $278,232 138,424
2025-06-30 $39,481 65,803
2024-12-31 $109,148 209,900
2024-09-30 $135,205 41,730
2024-09-30 $412,452 127,300
2024-09-30 $39,528 12,200
2024-06-30 $204,408 68,136
2024-06-30 $90,900 30,300
2024-03-31 $122,569 26,359
2024-03-31 $110,670 23,800
2023-12-31 $105,984 25,600
2023-12-31 $178,951 43,225
2023-09-30 $89,613 29,871
2023-09-30 $69,900 23,300
2023-06-30 $123,246 50,100
2023-06-30 $150,802 61,302
2023-03-31 $176,537 78,114
2023-03-31 $70,286 31,100
2022-12-31 $545,818 156,395
2022-12-31 $507,446 145,400
2022-12-31 $70,847 20,300
2022-09-30 $8,029,638 216,900
2022-09-30 $1,444,446 39,018
2022-09-30 $23,044,950 622,500
2022-06-30 $2,715,570 143,000
2022-06-30 $4,599,378 242,200
2022-03-31 $939,252 34,800
2022-03-31 $3,230,703 119,700
2021-12-31 $1,583,859 70,300
2021-12-31 $200,517 8,900
2021-12-31 $523,935 23,255
2021-09-30 $912,894 34,830
2021-09-30 $1,588,326 60,600
2021-06-30 $1,827,771 57,100
2021-06-30 $2,178,632 68,061
2021-06-30 $2,567,202 80,200
2021-03-31 $612,654 17,400
2021-03-31 $2,813,279 79,900
2021-03-31 $2,161,119 61,378
2020-12-31 $377,014 11,756
2020-12-31 $1,395,045 43,500
2020-09-30 $2,467,872 65,600
2020-06-30 $3,239,900 72,400
2020-06-30 $510,150 11,400

Report a Problem

Category
Description
Email (optional, for follow-up)